Back to Authors

Lindner, Dirk

Mayo Clinic

Takeda (Switzerland)

Citations 1

S0664 Disease Control and Changes in Individual Treatment Outcomes From Week 14 to Week 52 With Vedolizumab or Adalimumab in Ulcerative Colitis: A VARSITY Trial Post Hoc Analysis
Lindner, Dirk , Lirio, Richard A. , Agboton, Christian , Loftus, Edward V. , Danese, Silvio , Peyrin‐Biroulet, Laurent , Colombel, Jean‐Frédéric , Sands, Bruce E , Lindner, Dirk, Schreiber, Stefan

American Journal of Gastroenterology | October 24, 2020 | Volume: 115 | Issue: 1 | Pages: S332-S333

10.14309/01.ajg.0000704704.76894.ca Get It